Described herein are pharmaceutical packaging programs which stop oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medication, this sort of units which include a syringe by having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen and co